JPS6119630B2 - - Google Patents

Info

Publication number
JPS6119630B2
JPS6119630B2 JP58062554A JP6255483A JPS6119630B2 JP S6119630 B2 JPS6119630 B2 JP S6119630B2 JP 58062554 A JP58062554 A JP 58062554A JP 6255483 A JP6255483 A JP 6255483A JP S6119630 B2 JPS6119630 B2 JP S6119630B2
Authority
JP
Japan
Prior art keywords
lower alkyl
methyl
group
dihydrobenzofuran
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP58062554A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59186969A (ja
Inventor
Tetsuya Tawara
Seiji Hayano
Takemi Fukuda
Michihide Setoguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Yoshitomi Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical Industries Ltd filed Critical Yoshitomi Pharmaceutical Industries Ltd
Priority to JP58062554A priority Critical patent/JPS59186969A/ja
Priority to US06/591,363 priority patent/US4617314A/en
Priority to CA000450167A priority patent/CA1238906A/en
Priority to ES531121A priority patent/ES8507135A1/es
Priority to DE8484103843T priority patent/DE3468024D1/de
Priority to AT84103843T priority patent/ATE31307T1/de
Priority to EP84103843A priority patent/EP0124783B1/en
Priority to KR1019840001850A priority patent/KR910002883B1/ko
Publication of JPS59186969A publication Critical patent/JPS59186969A/ja
Publication of JPS6119630B2 publication Critical patent/JPS6119630B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
JP58062554A 1983-04-08 1983-04-08 ベンゾフラン−およびベンゾピランカルボキサミド誘導体 Granted JPS59186969A (ja)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP58062554A JPS59186969A (ja) 1983-04-08 1983-04-08 ベンゾフラン−およびベンゾピランカルボキサミド誘導体
US06/591,363 US4617314A (en) 1983-04-08 1984-03-20 Benzofuran- and benzopyran-carboxamide derivatives
CA000450167A CA1238906A (en) 1983-04-08 1984-03-21 Benzofuran- and benzopyran-carboxamide derivatives
ES531121A ES8507135A1 (es) 1983-04-08 1984-03-29 Procedimiento de preparar derivados benzofuran- o benzopirancar-boxamidicos
DE8484103843T DE3468024D1 (de) 1983-04-08 1984-04-06 Benzofuran- and benzopyran-carboxamide derivatives
AT84103843T ATE31307T1 (de) 1983-04-08 1984-04-06 Benzofuran- und benzopyrancarboxamid-derivate.
EP84103843A EP0124783B1 (en) 1983-04-08 1984-04-06 Benzofuran- and benzopyran-carboxamide derivatives
KR1019840001850A KR910002883B1 (ko) 1983-04-08 1984-04-07 벤조푸란-또는 벤조피란-카르복사미드 유도체의 제조방법

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58062554A JPS59186969A (ja) 1983-04-08 1983-04-08 ベンゾフラン−およびベンゾピランカルボキサミド誘導体

Publications (2)

Publication Number Publication Date
JPS59186969A JPS59186969A (ja) 1984-10-23
JPS6119630B2 true JPS6119630B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1986-05-17

Family

ID=13203591

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58062554A Granted JPS59186969A (ja) 1983-04-08 1983-04-08 ベンゾフラン−およびベンゾピランカルボキサミド誘導体

Country Status (8)

Country Link
US (1) US4617314A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0124783B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS59186969A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR910002883B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE31307T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1238906A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3468024D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8507135A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1297877C (en) * 1983-12-22 1992-03-24 Daniel Lednicer Benzofurancarboxamides useful as antiemetic or antipsychotic agents
US5175173A (en) * 1983-12-22 1992-12-29 Sun Jung Hui Carboxamides useful as antiemetic or antipsychotic agents
US4888353A (en) * 1986-02-28 1989-12-19 Erbamont, Inc. Carboxamides useful as antiemetic or antipsychotic agents
US5122528A (en) * 1983-12-22 1992-06-16 Erbamont, Inc. Analgesic use of benzobicyclic carboxamides
SE8503055D0 (sv) * 1985-06-19 1985-06-19 Astra Laekemedel Ab Piperonylcarboxamido derivatives
FR2593504B1 (fr) * 1986-01-30 1988-12-09 Ile De France Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
JPS62234083A (ja) * 1986-02-28 1987-10-14 アーバモント　インク　ディビーエイ　アドリヤ　ラボラトリーズ 鎮吐薬または精神病治療薬として有用なカルボキサミド類
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
DE3724756A1 (de) * 1987-07-25 1989-02-09 Basf Ag Basisch substituierte benzofurancarbonsaeureamide, verfahren zu ihrer herstellung und sie enthaltende therapeutische mittel
EP0314483A1 (en) * 1987-10-29 1989-05-03 Erbamont, Inc. Preparation of benzamides
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
US5122361A (en) * 1989-04-17 1992-06-16 Trustees Of The University Of Pennsylvania Dopamine receptor ligands and imaging agents
GB9005014D0 (en) 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
JPH07503480A (ja) * 1992-02-06 1995-04-13 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５−ｈｔ４拮抗薬としてのベンゾピラン，ベンゾチオピランおよびベンゾフラン誘導体
FR2699533A1 (fr) * 1992-12-21 1994-06-24 Mouhtaram Mohamed Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications.
GB9317987D0 (en) * 1993-08-26 1993-10-13 Glaxo Group Ltd Chemical compounds
AU763960B2 (en) * 1998-11-20 2003-08-07 F. Hoffmann-La Roche Ag Pyrrolidine derivatives-CCR-3 receptor antagonists
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US7728155B2 (en) 2003-10-24 2010-06-01 Wyeth Llc Dihydrobenzofuranyl alkanamines and methods for using same as cns agents
CN101198322A (zh) * 2005-04-22 2008-06-11 惠氏公司 用于治疗或预防抑郁症的新治疗组合
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
PT3395372T (pt) 2009-02-20 2022-05-05 Enhanx Biopharm Inc Sistema de entrega de medicamentos à base de glutationa
KR101741629B1 (ko) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN103908548A (zh) * 2014-04-02 2014-07-09 郭卫杰 一种用于治疗躁狂抑郁性精神病的中药及其制备方法
US20180305334A1 (en) * 2015-10-14 2018-10-25 Aquinnah Pharmaceuticals, Inc. Compounds, compositions and methods of use against stress granules

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL281394A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1961-07-25
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
MC807A1 (fr) * 1968-07-29 1970-07-30 Soc Et Scient Et Ind De L Ile Procédé de préparation de 3-alcoxy-thianaphtene-carboxamide substituées ou non
US3860619A (en) * 1969-05-09 1975-01-14 Novo Terapeutisk Labor As Sulphonylurea derivatives
GB1358684A (en) * 1970-06-15 1974-07-03 Novo Terapeutisk Labor As Carboxylic acids
DE2152230A1 (de) * 1971-10-20 1973-04-26 Boehringer Mannheim Gmbh Blutzuckersenkende sulfonylaminopyrimidine und verfahren zu deren herstellung
US3953462A (en) * 1973-10-29 1976-04-27 Xeerox Corporation Imaging process
US4205080A (en) * 1977-07-21 1980-05-27 Shell Oil Company 2,3-Dihydro benzofuran carboxamides
EP0108986A1 (en) * 1982-11-02 1984-05-23 Hokuriku Pharmaceutical Co.,Ltd N-substituted flavone-8-carboxamides

Also Published As

Publication number Publication date
EP0124783B1 (en) 1987-12-09
US4617314A (en) 1986-10-14
KR840009092A (ko) 1984-12-24
ES531121A0 (es) 1985-09-01
DE3468024D1 (de) 1988-01-21
CA1238906A (en) 1988-07-05
ES8507135A1 (es) 1985-09-01
EP0124783A1 (en) 1984-11-14
ATE31307T1 (de) 1987-12-15
JPS59186969A (ja) 1984-10-23
KR910002883B1 (ko) 1991-05-09

Similar Documents

Publication Publication Date Title
JPS6119630B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR910006863B1 (ko) 인돌-3-카르복사미드 유도체의 제조방법
JP2005527463A (ja) Ｃｎｓ疾患を治療するための５−ｈｔ６受容体アフィニティーを有する３−アリールスルホニル−７−ピペラジニル−インドール、−ベンゾフランおよび−ベンゾチオフェン
US6175015B1 (en) Fused indolecarboxamides: dopamine receptor subtype specific ligands
IE903286A1 (en) 3-(1-substituted-4-piperazinyl)-1h-indazoles, a process for¹their preparation and their use as medicaments
JPS6049192B2 (ja) 新規置換ベンズアミド、その製造方法及びこれを有効成分とする向精神薬
JPH08502741A (ja) ５−ｈｔ▲下４▼レセプターアンタゴニスト用のピペリジン誘導体
EP0487071A1 (en) Condensed heterocyclic compounds, their production and use
JPH09507484A (ja) 置換モルホリン誘導体およびその治療剤としての使用
JP2005525332A (ja) ５−ｈｔ６受容体アフィニティーを有するスルホニル化合物
JPH0240657B2 (ja) 3*44jihidorokarubosuchirirujudotai
JPH0267272A (ja) 薬理活性のあるベンゾイミダゾール誘導体
WO1996033186A1 (en) Substituted dihydrobenzofuran derivatives as 5-ht4 agonists
JPH08502283A (ja) ５−ｈｔ▲下４▼レセプターアンタゴニスト用の縮合環系ｎ−アルキルピペリジニル−４−メチルカルボン酸エステル／アミド
US4243666A (en) 4-Amino-2-piperidino-quinazolines
JP2002504549A (ja) ベンジルピペラジニル−およびベンジルピペリジニルエタノン誘導体、その調製、およびドーパミンｄ４受容体アンタゴニストとしてのその使用
KR950010073B1 (ko) 치환된 피리도[2,3-b][1,4]벤조디아제핀-6-온, 이의 제조방법 및 이를 함유하는 약제
US3177211A (en) 10-[(aminocarbamyl-1-piperidyl)-loweralkyl]-phenothiazines
JPH05194406A (ja) 新規アミド化合物
WO1994003425A2 (en) Carbostyril derivatives for the treatment of arrhythmia
JP3331047B2 (ja) インドリン誘導体
JPH0649700B2 (ja) ベンゾフラン化合物
WO2008043839A1 (en) Aryl piperazine derivatives useful for the treatment of neuropsychiatry disorders
JPH01168686A (ja) ベンゾフランおよびベンゾピラン化合物
JPH0232077A (ja) ベンゾフランおよびベンゾピラン化合物